New York State Common Retirement Fund Sells 3,500 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

New York State Common Retirement Fund lessened its position in The Cooper Companies, Inc. (NASDAQ:COO) by 3.4% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 100,050 shares of the medical device company’s stock after selling 3,500 shares during the period. New York State Common Retirement Fund owned approximately 0.05% of Cooper Companies worth $8,439,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of COO. T. Rowe Price Investment Management Inc. increased its stake in Cooper Companies by 2.1% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 7,678,965 shares of the medical device company’s stock worth $705,928,000 after acquiring an additional 155,233 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in Cooper Companies by 1.5% in the 4th quarter. JPMorgan Chase & Co. now owns 5,004,523 shares of the medical device company’s stock worth $460,066,000 after buying an additional 74,501 shares during the period. Geode Capital Management LLC lifted its holdings in Cooper Companies by 2.3% in the 4th quarter. Geode Capital Management LLC now owns 4,906,463 shares of the medical device company’s stock worth $449,907,000 after buying an additional 109,907 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in Cooper Companies by 517.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company’s stock worth $324,466,000 after buying an additional 2,957,421 shares during the period. Finally, Norges Bank purchased a new position in shares of Cooper Companies in the 4th quarter valued at approximately $217,906,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Trading Down 0.9%

Cooper Companies stock opened at $72.63 on Friday. The firm’s 50-day moving average is $74.03 and its 200-day moving average is $81.98. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.23 and a current ratio of 2.10. The Cooper Companies, Inc. has a 1 year low of $65.00 and a 1 year high of $112.38. The company has a market cap of $14.52 billion, a P/E ratio of 35.26, a PEG ratio of 1.77 and a beta of 0.99.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, topping analysts’ consensus estimates of $0.93 by $0.03. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The company had revenue of $1 billion during the quarter, compared to analyst estimates of $995.12 million. During the same period in the prior year, the business posted $0.85 EPS. The business’s revenue for the quarter was up 6.3% compared to the same quarter last year. On average, equities analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts recently weighed in on the company. Loop Capital set a $100.00 target price on Cooper Companies in a research report on Tuesday, June 17th. Mizuho reduced their price objective on Cooper Companies from $105.00 to $90.00 and set an “outperform” rating on the stock in a research note on Wednesday. Robert W. Baird cut their target price on Cooper Companies from $107.00 to $97.00 and set an “outperform” rating on the stock in a research note on Friday, May 30th. Wall Street Zen lowered Cooper Companies from a “buy” rating to a “hold” rating in a report on Saturday, July 12th. Finally, UBS Group upgraded Cooper Companies to a “buy” rating in a report on Tuesday, June 17th. Four equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat, Cooper Companies presently has an average rating of “Moderate Buy” and a consensus price target of $97.20.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.